Drug‐coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|83|3|427-435

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.83, Iss.3, 2014-02, pp. : 427-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Drug‐Coated Balloon for Coronary Indications: Too Little, Too Late

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 2, 2015-04 ,pp. : 218-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 497-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 278-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Eluting Balloon Technology for Native Non-Small Coronary Artery Disease: Another Crusade against Skepticism!

By  

Cardiology, Vol. 137, Iss. 1, 2016-12 ,pp. : 22-24

Karger

Access to resources Recommend Favorite

Integration of Geriatrics into Cardiology Fellowship Training Programs: A Joint Position Paper from the American Geriatrics Society and the Society of Geriatric Cardiology

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 7, 1998-07 ,pp. : 921-921

John Wiley & Sons Inc

Access to resources Recommend Favorite